US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

60 degrees pharmaceuticals, Inc.

2.15

+0.08003.86%

Volume:70.87K

Turnover:147.90K

Market Cap:3.17M

PE:-0.15

High:2.20

Open:2.07

Low:2.00

Close:2.07

Loading ...

Overview Company News Filings

Director Cheryl Xu Reports Acquisition of Common Shares in 60 Degrees Pharmaceuticals Inc

60 Degrees announces results from an insurance claims analysis on babesiosis

60 Degrees Pharm Is Maintained at Buy by Ascendiant Capital

60 Degrees Pharmaceuticals Q1 Operating Expenses USD 2.09 Million

THOMSON REUTERS

60 Degrees Pharmaceuticals Inc - Q1 2024 Net Product Revenues Increased 55% to $163.6 Thousand

THOMSON REUTERS

Press Release: 60 Degrees Pharmaceuticals Announces First Quarter 2025 Results

60 Degrees Q1 EPS $(1.56) Misses $(1.31) Estimate, Sales $183.01K Miss $227.00K Estimate

60 Degrees announces findings from online survey about babesiosis disease

Babesiosis Disease Burden in United States is Substantially Higher Than Official Estimates, According to Preliminary Results of 60 Degrees Pharma Survey

BRIEF-Geoff Dow to discuss Babesiosis at Healing Lyme Summit

Why 60 Degrees Pharmaceuticals, Inc. (SXTP) Went Down On Thursday?

Geoff Dow, PhD, Infectious Disease Product Development Expert, to Discuss Babesiosis at Healing Lyme Summit, April 15-21

Top Midday Gainers

MT Newswires Live

Dow Jumps Over 1,100 Points; US Small Business Sentiment Falls In March

60 Degrees Pharmaceuticals Signs Patent License Deal to Develop Tafenoquine for Tick-Borne Disease Treatment

MT Newswires Live

BRIEF-Sixty Degrees Pharmaceuticals Announces Patent License Agreement To Advance Development Of Tafenoquine

Sixty Degrees Pharmaceuticals Announces Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention With Yale School of Medicine and Yale School of Public Health

THOMSON REUTERS

Sixty Degrees Pharmaceuticals Announces Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention with Yale School of Medicine and Yale School of Public Health

60 Degrees Pharmaceuticals Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

60 Degrees Pharmaceuticals Announces 2024 Annual Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SXTP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SXTP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SXTP\",,,,,undefined,":{"symbol":"SXTP","market":"US","secType":"STK","nameCN":"60 degrees pharmaceuticals, Inc.","latestPrice":2.15,"timestamp":1750708800000,"preClose":2.07,"halted":0,"volume":70867,"delay":0,"floatShares":1289264,"shares":1472891,"eps":-14.643807,"marketStatus":"Pre-Mkt","change":0.08,"latestTime":"06-24 07:48:12 EDT","open":2.07,"high":2.2,"low":2,"amount":147901.625877,"amplitude":0.096618,"askPrice":2.33,"askSize":100,"bidPrice":2,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-14.643807,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1750771800000},"marketStatusCode":1,"adr":0,"listingDate":1686801600000,"exchange":"NASDAQ","adjPreClose":2.15,"postHourTrading":{"tag":"盘后","latestPrice":1.99,"preClose":2.15,"latestTime":"19:09 EDT","volume":630,"amount":1275.449,"timestamp":1750720174614},"volumeRatio":0.39382545328621826},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SXTP\",,,,,undefined,":{"symbol":"SXTP","floatShares":1289264,"roa":"-89.53%","roe":"-183.98%","lyrEps":-18.545406,"volumeRatio":0.39382545328621826,"shares":1472891,"dividePrice":0,"high":2.2,"amplitude":0.096618,"preClose":2.07,"low":2,"week52Low":1.41,"pbRate":"-0.58","psRate":"3.95","week52High":35.994,"institutionHeld":0,"latestPrice":2.15,"eps":-14.643807,"divideRate":0,"volume":70867,"delay":0,"ttmEps":-14.643807,"open":2.07,"prevYearClose":6.45,"prevWeekClose":2.07,"prevMonthClose":2.58,"prevQuarterClose":1.84,"fiveDayClose":2.21,"twentyDayClose":2.255,"sixtyDayClose":1.88},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SXTP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2541100724","title":"Director Cheryl Xu Reports Acquisition of Common Shares in 60 Degrees Pharmaceuticals Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2541100724","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541100724?lang=en_us&edition=fundamental","pubTime":"2025-06-06 08:53","pubTimestamp":1749171217,"startTime":"0","endTime":"0","summary":"Cheryl Xu, a Director at 60 Degrees Pharmaceuticals Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 60 Degrees Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 05, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250606:nNDL9gm9R9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director Cheryl Xu Reports Acquisition of Common Shares in 60 Degrees Pharmaceuticals Inc","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTP"],"gpt_icon":0},{"id":"2540743067","title":"60 Degrees announces results from an insurance claims analysis on babesiosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2540743067","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540743067?lang=en_us&edition=fundamental","pubTime":"2025-06-03 20:55","pubTimestamp":1748955329,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals (SXTP) announced results of an insurance claims analysis related to babesiosis and chronic fatigue, as conducted by Komo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/60-degrees-announces-results-from-an-insurance-claims-analysis-on-babesiosis-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/60-degrees-announces-results-from-an-insurance-claims-analysis-on-babesiosis-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2540769761","title":"60 Degrees Pharm Is Maintained at Buy by Ascendiant Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2540769761","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540769761?lang=en_us&edition=fundamental","pubTime":"2025-06-02 17:52","pubTimestamp":1748857920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SXTP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 02, 2025 05:52 ET (09:52 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP"],"gpt_icon":0},{"id":"2535808602","title":"60 Degrees Pharmaceuticals Q1 Operating Expenses USD 2.09 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2535808602","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535808602?lang=en_us&edition=fundamental","pubTime":"2025-05-16 04:31","pubTimestamp":1747341060,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nPLX914D3F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2535181808","title":"60 Degrees Pharmaceuticals Inc - Q1 2024 Net Product Revenues Increased 55% to $163.6 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2535181808","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535181808?lang=en_us&edition=fundamental","pubTime":"2025-05-16 04:31","pubTimestamp":1747341060,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nPLX914D3F:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SXTPW","SXTP","BK4007"],"gpt_icon":0},{"id":"2535808189","title":"Press Release: 60 Degrees Pharmaceuticals Announces First Quarter 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2535808189","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535808189?lang=en_us&edition=fundamental","pubTime":"2025-05-16 04:31","pubTimestamp":1747341060,"startTime":"0","endTime":"0","summary":"-- Q1 2024 net product revenues increased 55% year-over-year to $163.6. -- Gross profit increased 124% to $90.3 thousand.WASHINGTON, May 15, 2025  -- 60 Degrees Pharmaceuticals, Inc.  , a pharmaceutical company focused on developing new medicines for infectious diseases, reported today their financial results for the first fiscal quarter of the 2025 year, ended March 31, 2025.-- Net product revenues increased approximately 55% from $105.7 thousand for. the first quarter of 2024 to approximately $163.6 thousand for the first. quarter of 2025; the Company credits growth from domestic sales of. -- The Company achieved a gross profit of approximately $90.3 thousand in. the first quarter of 2025, compared with an approximate gross profit. of $40.2 thousand in the first quarter of 2024.-- Operating expenses were approximately $2.09 million in the first quarter. of 2025, compared with approximately $1.41 million in the first quarter. of 2024. Increased expenditures in sales and investor-relat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","R","BK4232","BK4022","SXTP"],"gpt_icon":0},{"id":"2535824808","title":"60 Degrees Q1 EPS $(1.56) Misses $(1.31) Estimate, Sales $183.01K Miss $227.00K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535824808","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535824808?lang=en_us&edition=fundamental","pubTime":"2025-05-15 22:23","pubTimestamp":1747319004,"startTime":"0","endTime":"0","summary":"60 Degrees (NASDAQ:SXTP) reported quarterly losses of $(1.56) per share which missed the analyst consensus estimate of $(1.31) by 19.08 percent. This is a 185.25 percent decrease over earnings of $1.83 per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45440351/60-degrees-q1-eps-1-56-misses-1-31-estimate-sales-183-01k-miss-227-00k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP"],"gpt_icon":0},{"id":"2529307332","title":"60 Degrees announces findings from online survey about babesiosis disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2529307332","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529307332?lang=en_us&edition=fundamental","pubTime":"2025-04-22 20:50","pubTimestamp":1745326255,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals (SXTP)announced findings that the actual burden of babesiosis in the United States may be significantly higher than Cent...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/60-degrees-announces-findings-from-online-survey-about-babesiosis-disease?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/60-degrees-announces-findings-from-online-survey-about-babesiosis-disease?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2529307763","title":"Babesiosis Disease Burden in United States is Substantially Higher Than Official Estimates, According to Preliminary Results of 60 Degrees Pharma Survey","url":"https://stock-news.laohu8.com/highlight/detail?id=2529307763","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529307763?lang=en_us&edition=fundamental","pubTime":"2025-04-22 20:44","pubTimestamp":1745325840,"startTime":"0","endTime":"0","summary":"In a survey representative of the general U.S. adult population, 1.26 percent of respondents – equivalent to about 3 million people – reported having received a medical diagnosis of babesiosis during their life-time; CDC data imply only about 73,000 people in that category.At the time they replied to the survey, 3.7 percent of respondents – equivalent to about 9.9 million people – reported they had been experiencing fatigue, a common symptom of babesiosis, for six months or longer.The online quantitative survey was conducted among a general adult population sample of 6,000 adults, with demographic variables  matched to U.S. census data for optimal representation of the U.S. population. Babesiosis was reported as a diagnosed medical condition experienced by 1.26 percent of respondents, implying that 3 million Americans may have experienced babesiosis . Moreover, approximately 17 percent of babesiosis patien","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/babesiosis-disease-burden-united-states-124400994.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4211","CDC","UBCP","SXTP","BK4007","SXTPW"],"gpt_icon":0},{"id":"2526598000","title":"BRIEF-Geoff Dow to discuss Babesiosis at Healing Lyme Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2526598000","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526598000?lang=en_us&edition=fundamental","pubTime":"2025-04-10 22:03","pubTimestamp":1744293838,"startTime":"0","endTime":"0","summary":"BRIEF-Geoff Dow to discuss Babesiosis at Healing Lyme SummitApril 10 (Reuters) - Dow Inc DOW.N:GEOFF DOW, PHD, INFECTIOUS DISEASE PRODUCT DEVELOPMENT EXPERT, TO DISCUSS BABESIOSIS AT HEALING LYME SUMM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250410:nTUABGJDPD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DOW","SXTP","BK4007","BK4588","BK4090","SXTPW","BK4585"],"gpt_icon":0},{"id":"2526956033","title":"Why 60 Degrees Pharmaceuticals, Inc. (SXTP) Went Down On Thursday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2526956033","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526956033?lang=en_us&edition=fundamental","pubTime":"2025-04-10 21:24","pubTimestamp":1744291448,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Stocks Fall Behind Amid Market Optimism. In this article, we are going to take a look at where 60 Degrees Pharmaceuticals, Inc.  stands against other stocks that fall behind amid market optimism.Wall Street’s main indices rebounded from hefty losses on Wednesday after President Donald Trump announced that the US will pause the imposition of higher tariffs on 75 countries for 90 days.In a post on Truth Social, Trump said that more than 75 countries have called to negotiate and have not retaliated in any way.“I have authorized a 90-day PAUSE, and a substantially lowered Reciprocal Tariff during this period, of 10%, also effective immediately,” he noted.Following the announcement, the Dow Jones jumped by 7.87 percent, the S&P 500 surged by 9.52 percent, and the tech-heavy Nasdaq soared by 12.16 percent.Despite the overall market optimism, 10 companies, predominantly in the biopharmaceutical sector, registered losses amid the lack of fresh developments to","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-60-degrees-pharmaceuticals-inc-132408554.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SXTPW","BK4007","SXTP"],"gpt_icon":0},{"id":"2526566242","title":"Geoff Dow, PhD, Infectious Disease Product Development Expert, to Discuss Babesiosis at Healing Lyme Summit, April 15-21","url":"https://stock-news.laohu8.com/highlight/detail?id=2526566242","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526566242?lang=en_us&edition=fundamental","pubTime":"2025-04-10 20:31","pubTimestamp":1744288260,"startTime":"0","endTime":"0","summary":"WASHINGTON, April  10, 2025  (GLOBE NEWSWIRE) -- Geoff Dow, infectious disease product development expert and chief executive officer of 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Deg","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/10/3059256/0/en/Geoff-Dow-PhD-Infectious-Disease-Product-Development-Expert-to-Discuss-Babesiosis-at-Healing-Lyme-Summit-April-15-21.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4211","SMMF","SXTP"],"gpt_icon":0},{"id":"2526841906","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2526841906","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526841906?lang=en_us&edition=fundamental","pubTime":"2025-04-09 02:21","pubTimestamp":1744136475,"startTime":"0","endTime":"0","summary":"FatPipe  shares surged over 200% in their trading debut on Nasdaq Tuesday after the company priced its initial public offering of 695,656 shares at $5.75 apiece to raise about $4 million.60 Degrees Pharmaceuticals  said it signed a patent license deal with Yale School of Medicine and Yale School of Public Health to jointly develop and commercialize Tafenoquine for the treatment and prevention of tick-borne disease babesiosis.Shares surged 64%, with intraday trading volume catapulted to over 73.8 million from a daily average of about 419,000.Price: 18.25, Change: +12.50, Percent Change: +217.30","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FATN","SXTP","BK4007"],"gpt_icon":0},{"id":"2525813635","title":"Dow Jumps Over 1,100 Points; US Small Business Sentiment Falls In March","url":"https://stock-news.laohu8.com/highlight/detail?id=2525813635","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525813635?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:57","pubTimestamp":1744120644,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/04/44685640/dow-jumps-over-1100-points-us-small-business-sentiment-falls-in-march","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USJW.SI","NVIW.SI","QLD","TQQQ","BK4007","NAOV","BK4122","CYCU","PCOM","TSYW.SI","BK4173","BK4539","PSQ","QID","BK4123","SXTP","BK4082","BK4233","MNQmain","NQmain","USAW.SI","SQQQ","CVRX","XHG",".IXIC"],"gpt_icon":1},{"id":"2525135808","title":"60 Degrees Pharmaceuticals Signs Patent License Deal to Develop Tafenoquine for Tick-Borne Disease Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2525135808","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525135808?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:53","pubTimestamp":1744120430,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals  said Tuesday it signed a patent license deal with Yale School of Medicine and Yale School of Public Health to jointly develop and commercialize Tafenoquine for the treatment and prevention of tick-borne disease babesiosis.The deal comes after the start of collaboration between researchers from the organizations to look into the activity of tafenoquine against babesiosis, which is caused by microscopic parasites that infect red blood cells, the company said.Tafenoquine currently doesn't have US Food and Drug Administration approval for babesiosis treatment and prevention, according to the company.Shares of 60 Degrees Pharmaceuticals rose 83% in recent trading.Price: 3.43, Change: +1.64, Percent Change: +91.68","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2525115890","title":"BRIEF-Sixty Degrees Pharmaceuticals Announces Patent License Agreement To Advance Development Of Tafenoquine","url":"https://stock-news.laohu8.com/highlight/detail?id=2525115890","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525115890?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:29","pubTimestamp":1744118945,"startTime":"0","endTime":"0","summary":"BRIEF-Sixty Degrees Pharmaceuticals Announces Patent License Agreement To Advance Development Of TafenoquineApril 8 (Reuters) - 60 Degrees Pharmaceuticals Inc SXTP.O:SIXTY DEGREES PHARMACEUTICALS ANNO","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nFWN3QM1XQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2525754891","title":"Sixty Degrees Pharmaceuticals Announces Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention With Yale School of Medicine and Yale School of Public Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2525754891","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525754891?lang=en_us&edition=fundamental","pubTime":"2025-04-08 20:31","pubTimestamp":1744115498,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nFWN3QM1XQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2525198894","title":"Sixty Degrees Pharmaceuticals Announces Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention with Yale School of Medicine and Yale School of Public Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2525198894","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525198894?lang=en_us&edition=fundamental","pubTime":"2025-04-08 20:31","pubTimestamp":1744115460,"startTime":"0","endTime":"0","summary":"WASHINGTON, D.C., April  08, 2025  (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company”), a pharmaceutical company focused on developing new medici","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/08/3057618/0/en/Sixty-Degrees-Pharmaceuticals-Announces-Patent-License-Agreement-to-Advance-Development-of-Tafenoquine-for-Babesiosis-Treatment-and-Prevention-with-Yale-School-of-Medicine-and-Yale.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1878469433.USD","SXTP","BK4139","ALT","BK4599","BK4007"],"gpt_icon":0},{"id":"2523692634","title":"60 Degrees Pharmaceuticals Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag","url":"https://stock-news.laohu8.com/highlight/detail?id=2523692634","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523692634?lang=en_us&edition=fundamental","pubTime":"2025-03-29 21:27","pubTimestamp":1743254840,"startTime":"0","endTime":"0","summary":"These 15 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.NasdaqCM:SXTP Earnings and Revenue Growth March 29th 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue missed analyst estimates by 2.4%. Earnings per share  exceeded analyst estimates by 24%.Looking ahead, revenue is forecast to grow 52% p.a. on average during the next 3 years, compared to a 8.4% growth forecast for the Pharmaceuticals industry in the US.The company's shares are up 4.0% from a week ago.It is worth noting though that we have found 5 warning signs for 60 Degrees Pharmaceuticals (4 don't sit too well with us!) that you need to take into consideration.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/60-degrees-pharmaceuticals-full-2024-132720774.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SXTPW","SXTP"],"gpt_icon":0},{"id":"2522352291","title":"60 Degrees Pharmaceuticals Announces 2024 Annual Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2522352291","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522352291?lang=en_us&edition=fundamental","pubTime":"2025-03-28 18:59","pubTimestamp":1743159540,"startTime":"0","endTime":"0","summary":"FY 2024 net product revenues increased 140% to $607.6 thousand.FY 2024 gross profit increased $443.8 thousand from  to $222.8 thousand.WASHINGTON, March 28, 2025  -- 60 Degrees Pharmaceuticals, Inc. , a pharmaceutical company focused on developing new medicines for infectious diseases, reported today their financial results for the 2024 fiscal year, ended December 31, 2024.Net product revenues increased 140% from $253.6 thousand for fiscal year 2023 to $607.6 thousand for fiscal year 2024; the Company credits growth from domestic commercial sales of ARAKODA.The Company achieved a gross profit of approximately $222.8 thousand in fiscal year 2024, compared to an approximate gross loss of $221 thousand in fiscal year 2023. Increased sales volume allowed the Company to overcome fixed cost of goods expense associated with the Drug Supply Chain Security Act that previously led to a gross loss.The Company commenced a randomized evaluation of tafenoquine versus placebo in hospitalized patients","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/60-degrees-pharmaceuticals-announces-2024-105900330.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SXTPW","SXTP","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":55,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SXTP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-24","symbol":"SXTP","defaultRemindTime":1740407400000,"type":"split","dateTimestamp":1740373200000,"forFactor":5,"toFactor":1,"ratio":5},{"market":"US","date":"2024-08-12","symbol":"SXTP","defaultRemindTime":1723469400000,"type":"split","dateTimestamp":1723435200000,"forFactor":12,"toFactor":1,"ratio":12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SXTP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SXTP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":2,"updateTime":1698033600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SXTP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SXTP","date":"2025-06-23","current":-0.297332,"percent":0.933333,"low":-5.827686,"twenty":-1.530471,"median":-0.840293,"eighty":-0.383215,"high":-0.148542,"avg":-1.143075,"sd":1.112994,"marketCap":3048884},"quantilePoints":[{"date":"2023-07-14","current":-3.206044,"twenty":-3.575483,"median":-3.312205,"eighty":-3.248508,"marketCap":25229961},{"date":"2023-07-21","current":-2.066589,"twenty":-3.269741,"median":-2.519541,"eighty":-2.109053,"marketCap":16263021},{"date":"2023-07-28","current":-1.549942,"twenty":-3.005047,"median":-2.066589,"eighty":-1.612223,"marketCap":12197266},{"date":"2023-08-04","current":-1.436704,"twenty":-2.556343,"median":-1.68795,"eighty":-1.51314,"marketCap":11306141},{"date":"2023-08-11","current":-1.082836,"twenty":-2.270417,"median":-1.578251,"eighty":-1.364515,"marketCap":8521377},{"date":"2023-08-18","current":-1.132378,"twenty":-2.130285,"median":-1.514555,"eighty":-1.186166,"marketCap":8911244},{"date":"2023-08-25","current":-1.075759,"twenty":-1.995815,"median":-1.493323,"eighty":-1.119638,"marketCap":8465682},{"date":"2023-09-01","current":-0.896195,"twenty":-1.818881,"median":-1.298696,"eighty":-1.075759,"marketCap":8118769},{"date":"2023-09-08","current":-0.774624,"twenty":-1.702813,"median":-1.231461,"eighty":-0.96014,"marketCap":7017437},{"date":"2023-09-15","current":-0.729811,"twenty":-1.64761,"median":-1.146532,"eighty":-0.891125,"marketCap":6611469},{"date":"2023-09-22","current":-0.512148,"twenty":-1.583913,"median":-1.121762,"eighty":-0.799591,"marketCap":4639628},{"date":"2023-09-29","current":-0.473737,"twenty":-1.572589,"median":-1.082836,"eighty":-0.74506,"marketCap":4291655},{"date":"2023-10-06","current":-0.428924,"twenty":-1.54428,"median":-1.043911,"eighty":-0.582824,"marketCap":3885688},{"date":"2023-10-13","current":-0.449858,"twenty":-1.518801,"median":-0.952467,"eighty":-0.507026,"marketCap":4075333},{"date":"2023-10-20","current":-0.524952,"twenty":-1.507478,"median":-0.898787,"eighty":-0.48823,"marketCap":4755618},{"date":"2023-10-27","current":-0.423162,"twenty":-1.507478,"median":-0.893026,"eighty":-0.483288,"marketCap":3833492},{"date":"2023-11-03","current":-0.377709,"twenty":-1.498985,"median":-0.86425,"eighty":-0.474121,"marketCap":3421725},{"date":"2023-11-10","current":-0.384111,"twenty":-1.459352,"median":-0.781026,"eighty":-0.464774,"marketCap":3479721},{"date":"2023-11-17","current":-0.435326,"twenty":-1.364515,"median":-0.768158,"eighty":-0.451894,"marketCap":3943683},{"date":"2023-11-24","current":-0.957437,"twenty":-1.302234,"median":-0.768222,"eighty":-0.451215,"marketCap":3282536},{"date":"2023-12-01","current":-1.048783,"twenty":-1.272509,"median":-0.817837,"eighty":-0.455018,"marketCap":3595711},{"date":"2023-12-08","current":-1.126596,"twenty":-1.237122,"median":-0.883455,"eighty":-0.458974,"marketCap":3862490},{"date":"2023-12-15","current":-1.209483,"twenty":-1.239655,"median":-0.898787,"eighty":-0.463494,"marketCap":4146667},{"date":"2023-12-22","current":-1.860743,"twenty":-1.313345,"median":-0.952467,"eighty":-0.469896,"marketCap":6379488},{"date":"2023-12-29","current":-1.877659,"twenty":-1.436704,"median":-0.957437,"eighty":-0.473737,"marketCap":6437483},{"date":"2024-01-05","current":-1.843828,"twenty":-1.498985,"median":-0.99083,"eighty":-0.473737,"marketCap":6321493},{"date":"2024-01-12","current":-1.684903,"twenty":-1.535158,"median":-1.005049,"eighty":-0.473737,"marketCap":5776626},{"date":"2024-01-19","current":-1.239932,"twenty":-1.578554,"median":-1.044215,"eighty":-0.473993,"marketCap":4251059},{"date":"2024-01-26","current":-0.829046,"twenty":-1.566927,"median":-1.048783,"eighty":-0.474761,"marketCap":2842352},{"date":"2024-02-02","current":-0.925149,"twenty":-1.540086,"median":-1.013507,"eighty":-0.475465,"marketCap":3171838},{"date":"2024-02-09","current":-0.910618,"twenty":-1.523834,"median":-0.998035,"eighty":-0.47745,"marketCap":3122019},{"date":"2024-02-16","current":-1.032034,"twenty":-1.51597,"median":-0.998035,"eighty":-0.482239,"marketCap":3538288},{"date":"2024-02-23","current":-0.952597,"twenty":-1.507478,"median":-0.999534,"eighty":-0.485478,"marketCap":3265942},{"date":"2024-03-01","current":-0.872837,"twenty":-1.504647,"median":-0.997482,"eighty":-0.487014,"marketCap":2992488},{"date":"2024-03-08","current":-0.96067,"twenty":-1.485273,"median":-0.987859,"eighty":-0.492942,"marketCap":3293619},{"date":"2024-03-15","current":-0.79114,"twenty":-1.449798,"median":-0.959539,"eighty":-0.498115,"marketCap":2712392},{"date":"2024-03-22","current":-0.916107,"twenty":-1.420017,"median":-0.955017,"eighty":-0.500624,"marketCap":3140839},{"date":"2024-03-28","current":-0.855077,"twenty":-1.353268,"median":-0.952532,"eighty":-0.505746,"marketCap":2931598},{"date":"2024-04-05","current":-0.849647,"twenty":-1.338044,"median":-0.936451,"eighty":-0.512148,"marketCap":3199516},{"date":"2024-04-12","current":-0.816395,"twenty":-1.316389,"median":-0.933222,"eighty":-0.524952,"marketCap":3074302},{"date":"2024-04-19","current":-0.757247,"twenty":-1.308779,"median":-0.92967,"eighty":-0.530713,"marketCap":2851568},{"date":"2024-04-26","current":-0.717764,"twenty":-1.281002,"median":-0.922727,"eighty":-0.537755,"marketCap":2702887},{"date":"2024-05-03","current":-0.712848,"twenty":-1.27038,"median":-0.915462,"eighty":-0.550879,"marketCap":2684374},{"date":"2024-05-10","current":-0.706703,"twenty":-1.25977,"median":-0.903415,"eighty":-0.619133,"marketCap":2661232},{"date":"2024-05-17","current":-3.509711,"twenty":-1.27038,"median":-0.90138,"eighty":-0.641256,"marketCap":2580238},{"date":"2024-05-24","current":-4.594449,"twenty":-1.338044,"median":-0.91304,"eighty":-0.64525,"marketCap":3377706},{"date":"2024-05-31","current":-4.661966,"twenty":-1.461121,"median":-0.918206,"eighty":-0.666636,"marketCap":3427342},{"date":"2024-06-07","current":-5.728069,"twenty":-1.522366,"median":-0.927087,"eighty":-0.675178,"marketCap":4211110},{"date":"2024-06-14","current":-4.678752,"twenty":-1.578453,"median":-0.931607,"eighty":-0.675977,"marketCap":3439683},{"date":"2024-06-21","current":-4.565851,"twenty":-1.664999,"median":-0.933222,"eighty":-0.682122,"marketCap":3356681},{"date":"2024-06-28","current":-4.459591,"twenty":-1.683685,"median":-0.93467,"eighty":-0.688267,"marketCap":3278562},{"date":"2024-07-05","current":-3.848597,"twenty":-1.749099,"median":-0.942586,"eighty":-0.700189,"marketCap":2829377},{"date":"2024-07-12","current":-4.084361,"twenty":-1.843828,"median":-0.952597,"eighty":-0.706457,"marketCap":3002704},{"date":"2024-07-15","current":-4.07606,"twenty":-1.847211,"median":-0.952597,"eighty":-0.70658,"marketCap":2996601},{"date":"2024-08-02","current":-2.282925,"twenty":-1.860743,"median":-0.955017,"eighty":-0.706703,"marketCap":1678340},{"date":"2024-08-09","current":-1.534126,"twenty":-1.877659,"median":-0.959539,"eighty":-0.710605,"marketCap":1127845},{"date":"2024-08-16","current":-1.068072,"twenty":-1.877659,"median":-0.987859,"eighty":-0.712848,"marketCap":1678338},{"date":"2024-08-23","current":-2.160665,"twenty":-1.877659,"median":-0.997482,"eighty":-0.717764,"marketCap":3395207},{"date":"2024-08-30","current":-1.710527,"twenty":-1.890582,"median":-0.999534,"eighty":-0.729811,"marketCap":2687872},{"date":"2024-09-06","current":-1.620499,"twenty":-1.88984,"median":-1.0072,"eighty":-0.729811,"marketCap":2546405},{"date":"2024-09-13","current":-1.530471,"twenty":-1.880058,"median":-1.014951,"eighty":-0.730006,"marketCap":2404938},{"date":"2024-09-20","current":-1.521468,"twenty":-1.877659,"median":-1.04133,"eighty":-0.731038,"marketCap":2390791},{"date":"2024-09-27","current":-1.468799,"twenty":-1.869809,"median":-1.049471,"eighty":-0.737686,"marketCap":2308028},{"date":"2024-10-04","current":-1.255991,"twenty":-1.862164,"median":-1.066844,"eighty":-0.740259,"marketCap":1973628},{"date":"2024-10-11","current":-1.244142,"twenty":-1.847211,"median":-1.075002,"eighty":-0.740502,"marketCap":1955009},{"date":"2024-10-18","current":-1.232293,"twenty":-1.843828,"median":-1.079298,"eighty":-0.743697,"marketCap":1936390},{"date":"2024-10-25","current":-1.016642,"twenty":-1.840904,"median":-1.082836,"eighty":-0.754697,"marketCap":1597522},{"date":"2024-10-31","current":-0.975171,"twenty":-1.832216,"median":-1.075759,"eighty":-0.763051,"marketCap":1532355},{"date":"2024-11-08","current":-1.26784,"twenty":-1.806613,"median":-1.075381,"eighty":-0.767663,"marketCap":1992247},{"date":"2024-11-15","current":-1.125653,"twenty":-1.78406,"median":-1.082836,"eighty":-0.768196,"marketCap":1768818},{"date":"2024-11-22","current":-0.205615,"twenty":-1.766768,"median":-1.075381,"eighty":-0.742898,"marketCap":1627312},{"date":"2024-11-29","current":-0.307708,"twenty":-1.757765,"median":-1.071273,"eighty":-0.734485,"marketCap":2435312},{"date":"2024-12-06","current":-0.345446,"twenty":-1.750257,"median":-1.065617,"eighty":-0.722583,"marketCap":2733983},{"date":"2024-12-13","current":-0.47898,"twenty":-1.738613,"median":-1.055566,"eighty":-0.706334,"marketCap":3790817},{"date":"2024-12-20","current":-0.40931,"twenty":-1.727188,"median":-1.048783,"eighty":-0.67358,"marketCap":3239425},{"date":"2024-12-27","current":-0.38899,"twenty":-1.717281,"median":-1.039648,"eighty":-0.641313,"marketCap":3078603},{"date":"2025-01-03","current":-0.380281,"twenty":-1.712721,"median":-1.016642,"eighty":-0.550879,"marketCap":3009679},{"date":"2025-01-10","current":-0.316417,"twenty":-1.710966,"median":-1.012063,"eighty":-0.522391,"marketCap":2504236},{"date":"2025-01-17","current":-0.239606,"twenty":-1.690028,"median":-1.00281,"eighty":-0.496592,"marketCap":1896327},{"date":"2025-01-24","current":-0.255137,"twenty":-1.68399,"median":-0.998035,"eighty":-0.483288,"marketCap":2019241},{"date":"2025-01-31","current":-0.232233,"twenty":-1.673079,"median":-0.992315,"eighty":-0.474953,"marketCap":1837972},{"date":"2025-02-07","current":-0.153564,"twenty":-1.664392,"median":-0.980029,"eighty":-0.471176,"marketCap":1215358},{"date":"2025-02-14","current":-0.582606,"twenty":-1.637571,"median":-0.96067,"eighty":-0.473737,"marketCap":4610947},{"date":"2025-02-21","current":-0.439583,"twenty":-1.620499,"median":-0.957437,"eighty":-0.473737,"marketCap":3479015},{"date":"2025-02-28","current":-0.349879,"twenty":-1.606995,"median":-0.952597,"eighty":-0.455018,"marketCap":2769070},{"date":"2025-03-07","current":-0.295909,"twenty":-1.586175,"median":-0.942586,"eighty":-0.438837,"marketCap":2341926},{"date":"2025-03-14","current":-0.325686,"twenty":-1.5827,"median":-0.933946,"eighty":-0.428924,"marketCap":2577592},{"date":"2025-03-21","current":-0.36849,"twenty":-1.578554,"median":-0.931607,"eighty":-0.419612,"marketCap":2916361},{"date":"2025-03-28","current":-0.338713,"twenty":-1.572643,"median":-0.927312,"eighty":-0.40931,"marketCap":2680696},{"date":"2025-04-04","current":-0.34102,"twenty":-1.562151,"median":-0.925149,"eighty":-0.394645,"marketCap":2710119},{"date":"2025-04-11","current":-0.574544,"twenty":-1.556789,"median":-0.915785,"eighty":-0.39251,"marketCap":4565962},{"date":"2025-04-17","current":-0.587517,"twenty":-1.553338,"median":-0.908035,"eighty":-0.394595,"marketCap":4669064},{"date":"2025-04-25","current":-0.543037,"twenty":-1.552371,"median":-0.898993,"eighty":-0.395957,"marketCap":4315570},{"date":"2025-05-02","current":-0.459635,"twenty":-1.549767,"median":-0.893026,"eighty":-0.401762,"marketCap":3652769},{"date":"2025-05-09","current":-0.418861,"twenty":-1.547598,"median":-0.874888,"eighty":-0.406988,"marketCap":3328733},{"date":"2025-05-16","current":-0.398474,"twenty":-1.541724,"median":-0.870254,"eighty":-0.406988,"marketCap":3166715},{"date":"2025-05-23","current":-0.323906,"twenty":-1.541274,"median":-0.86425,"eighty":-0.394595,"marketCap":3321369},{"date":"2025-05-30","current":-0.382079,"twenty":-1.539474,"median":-0.855077,"eighty":-0.384111,"marketCap":3917890},{"date":"2025-06-06","current":-0.425171,"twenty":-1.534126,"median":-0.848946,"eighty":-0.384111,"marketCap":4359757},{"date":"2025-06-13","current":-0.327497,"twenty":-1.530471,"median":-0.844971,"eighty":-0.384111,"marketCap":3358191},{"date":"2025-06-20","current":-0.31026,"twenty":-1.530471,"median":-0.840362,"eighty":-0.383346,"marketCap":3181444},{"date":"2025-06-23","current":-0.297332,"twenty":-1.530471,"median":-0.840293,"eighty":-0.383215,"marketCap":3048884}],"updateTime":1750765437875}}}